Literature DB >> 8578186

Helicobacter pylori infection in Finnish children and adolescents. A serologic cross-sectional and follow-up study.

M Ashorn1, M Mäki, M Hällström, M Uhari, H K Akerblom, J Viikari, A Miettinen.   

Abstract

BACKGROUND: The purpose was to examine the epidemiology of Helicobacter pylori infection in Finnish children and adolescents.
METHODS: Blood samples taken from healthy subjects (n = 461) 3-18 years old were studied cross-sectionally for the presence of H. pylori antibodies. Additionally, blood samples drawn in 1980, 1983, 1986, and 1989 from 74 children born in 1977 were tested. Serum IgG-class antibodies to H. pylori were determined by an enzyme immunoassay.
RESULTS: In the cross-sectional series the mean antibody levels and the percentage of seropositive children increased with age. The overall seroprevalence was 10.2%. During the follow-up period from 3 to 12 years of age the seropositivity increased from 4.6% to 5.7%. On the basis of the seroconversions between 3 and 12 years of age the annual incidence of H. pylori infection was calculated to be only 0.3%.
CONCLUSIONS: In children seropositivity for H. pylori of the IgG class is often a sign of an infection acquired in early childhood. It seems likely that the age-dependent increase in the seropositivity reflects cumulation of a chronic infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8578186     DOI: 10.3109/00365529509101594

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  16 in total

1.  Non-invasive testing for Helicobacter pylori.

Authors:  M A Stone
Journal:  Postgrad Med J       Date:  1999-02       Impact factor: 2.401

2.  Age-specific Helicobacter pylori seropositivity rates of children in an impoverished urban area of northeast Brazil.

Authors:  Anastasia Mitchell; Terezinha M J Silva; Leah J Barrett; Aldo A M Lima; Richard L Guerrant
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

Review 3.  How labile is gastric infection with H pylori?

Authors:  M Hobsley; F-I Tovey; J Holton
Journal:  World J Gastroenterol       Date:  2007-09-21       Impact factor: 5.742

4.  Seroepidemiological study of Helicobacter pylori infection in infancy.

Authors:  M Ashorn; A Miettinen; T Ruuska; P Laippala; M Mäki
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-03       Impact factor: 5.747

5.  Clinical Application of the DiversiLab Microbial Typing System Using Repetitive Sequence-Based PCR for Characterization of Helicobacter pylori in Japan.

Authors:  Norihito Morimoto; Hiroaki Takeuchi; Yoshie Nishida; Mie Morisawa; Tomoe Yoshikawa; Tamae Morita; Miyuki Morimoto; Chizuko Sugimoto; Yoshihisa Matsumura; Tetsuro Sugiura
Journal:  J Clin Lab Anal       Date:  2014-05-05       Impact factor: 2.352

Review 6.  Transmission of Helicobacter pylori.

Authors:  M A Stone
Journal:  Postgrad Med J       Date:  1999-04       Impact factor: 2.401

7.  Seroepidemiology of Helicobacter pylori infection in a cohort of children monitored from 6 months to 11 years of age.

Authors:  M Granström; Y Tindberg; M Blennow
Journal:  J Clin Microbiol       Date:  1997-02       Impact factor: 5.948

Review 8.  Sex hormones, hormonal interventions, and gastric cancer risk: a meta-analysis.

Authors:  M Constanza Camargo; Yasuyuki Goto; Jovanny Zabaleta; Douglas R Morgan; Pelayo Correa; Charles S Rabkin
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-10-25       Impact factor: 4.254

9.  Transient and persistent Helicobacter pylori colonization in Native American children.

Authors:  Guillermo I Pérez-Pérez; R Bradley Sack; Raymond Reid; Mathuram Santosham; Janne Croll; Martin J Blaser
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

10.  Persistent H. pylori colonization in early acquisition age of mice related with higher gastric sialylated Lewis x, IL-10, but lower interferon-γ expressions.

Authors:  Yao-Jong Yang; Hsiao-Bai Yang; Jiunn-Jong Wu; Bor-Shyang Sheu
Journal:  J Biomed Sci       Date:  2008-12-27       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.